Overview

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

This study assessed the efficacy and safety of combination therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in patients with stage II Hypertension.

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine
Hydrochlorothiazide